Gallbladder cancer cells are stimulated by hepatocyte growth factor (HGF) in vitro and in vivo. We constructed an adenovirus vector, AdCMV.NK4, carrying the HGF antagonist HGF/NK4 (NK4) and evaluated whether or not this vector can suppress the peritoneal implantation of gallbladder cancer in a novel peritoneal injury mouse model. A human gallbladder cancer cell line (GBd1) and human peritoneal mesothelial cells infected with the adenovirus vector produced a substantial level of NK4 protein. An invasion of GB-d1 cells was determined by a coculture with AdCMV.NK4-infected human mesothelial cells in vitro. Both the invasion and migration of GB-d1 cells were dramatically inhibited by this vector in a multiplicity of infection (MOI)-dependent manner. GB-d1 cells were intraperitoneally injected into the nude mice with peritoneal injury, followed by either AdCMV.NK4 or a control vector (AdCMV.LacZ). The incidence and the size of the metastatic tumor drastically decreased by AdCMV.NK4 (MOI 100: n ¼ 4, Po.0001). Real-time PCR analysis revealed a transient elevation of mouse HGF mRNA expression at the peritoneal injury sites. AdCMV.NK4 has been suggested to induce the inhibition of the implantation and growth of gallbladder cancer cells in vivo through its anti-HGF activity, and the use of NK4 gene transfer could be an effective modality for preventing peritoneal metastasis of gallbladder cancer.
G
allbladder cancer is one of the most lethal neoplasms found in the digestive tract even if a radical operation is performed. An early diagnosis of gallbladder carcinoma is rarely achieved because of a lack of specific signs and symptoms. Most (75%) of the patients tend to demonstrate unresectable disease at the time of surgical evaluation. 1 Actually, its survival rates are also reported to be very short after diagnosis (5-year survival rate is 13-30%). 2 Surgical treatment becomes ineffective when biliary cancer cells infiltrate the hepatic hilum and surrounding soft tissue. Once cancer cells reach beyond the subserosa of the gallbladder wall, they readily spread to the draining lymph nodes and other organs or disseminate into the peritoneal cavity. Moreover, neither chemical nor radiation therapy is effective. 3 We, surgeon, often encounter the implantation, metastasis or regression that occurs at the operative wound healing sites, when an operation is performed on far advanced cancer. Therefore, an alternative approach to effectively neutralize these biliary cancer cells is desperately needed.
Hepatocyte growth factor (HGF) was discovered by Nakamura et al 4 in 1984 as a factor stimulating the DNA synthesis of cultivated hepatocytes. It was thereafter cloned and sequenced in 1989. [5] [6] [7] Many types of malignant cells, mainly adenocarcinomas, are responsive to HGF, which stimulates cell proliferation, invasion and metastasis through an association with its receptor c-met product (HGFR). [8] [9] [10] We previously reported that HGF induced invasion of human gallbladder cancer cells into collagen gel and matrigelt, and such induction was neutralized by an antibody against HGF. Interestingly, HGF is produced by such nonepithelial stromal cells as fibroblasts 11, 12 or endothelial cells, 13 and this production was also stimulated by some cancer-producing cytokines of IL-1, PDGF or bFGF.
14 Autostimulation system between cancer cells and stromal cells is thus thought to be an important process of malignant neoplasm progression. Intrinsically, HGF has been shown to promote organ formation, tissue repair and wound healing in many normal organs. 15, 16 Therefore, we hypothesized that gallbladder cancer implantation at the surgical wound sites correlates closely with HGF activated in the process of wound healing.
HGF is a heterodimeric molecule consisting of a 69 kDa a subunit and a 34 kDa b subunit. The a subunit has four kringle domains that are associated with its tyrosinkinase receptor, c-met (HGF receptor). The receptor phosphorylates itself and transducts several signals that stimulate cell proliferation and motility. 17, 18 To terminate the signal transduction, we constructed an HGF antagonist HGF/NK4 (NK4) that have four kringle domains and a hairpin domain, and NK4 showed a significant inhibitory effect on gallbladder cancer cells developed in both in vitro and in vivo models. 19, 20 However, the production and purification of NK4 protein proved to be difficult and too expensive for us to use in an animal model. We herein constructed an adenovirus vector, AdCMV.NK4, expressing NK4 gene under CMV promoter, and considered whether it could prevent peritoneal implantation of human gallbladder cancer in a peritoneal injury mouse model.
Materials and methods

Materials
Human recombinant HGF was purified from the conditioned medium of Chinese hamster ovary cells transfected with human HGF cDNA. 6, 8 Isolation and culture of human peritoneal mesothelial cells Peritoneal mesothelial cells were obtained from resected tissue specimens of the greater omentum from patients who had undergone a laparotomy for an early gastric cancer. Informed consent was obtained from the surgical patients before surgery. Isolation and culture were performed as previously described. 21 Briefly, after the tissue was digested with 0.25% trypsin-EDTA (Gibco BRL, NY) at 371C for 20 min, Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS) was added to the culture. The omentum sheets were then removed and the suspension was centrifuged. The cells were collected and suspended in DMEM with 10% FBS and cultured in 60 mm dishes (Becton Dickinson, NJ) in an atmosphere of 95% air and 5% CO 2 at 371C. Mesothelial cells proliferated to form confluent cell sheets within 2 weeks.
Gallbladder cancer cell line and cell culture GB-d1 is an established cell line of human gallbladder adenocarcinoma described previously. 22 Cells were grown in DMEM supplemented with streptomycin, penicillin and 10% FBS at 371C in a humidified atmosphere containing 5% CO 2 .
Recombinant adenovirus vector
The replication-deficient adenovirus vectors used in this study are E1a-, partially E1b-, and E3-deleted vectors based on human adenovirus type 5 pJM17. 23 AdCMV.NK4 was prepared by inserting the human NK4 genomic DNA sequence into pSV2
þ . 24 The resulting plasmids were cotransfected with pJM17 into the human embryonic kidney cell line 293 to generate the respective adenovirus vectors. 25 These were cloned by infecting 293 cultures at limiting dilutions and then were amplified by further propagation in 293 cells. The defective viral particles were purified by CsCl centrifugation and dialyzed against PBS with 10% glycerol. The total number of viral particles in the viral sample was measured by OD 260 (where an OD 260 of 1 is equal to 10 12 particles). Viral titers were determined by a plaque assay on 293 cells. For control experiments, a Lac-Z adenovirus vector was used in this study.
Assay for NK4 expression in vitro
Human mesothelial cells and GB-d1 cells were initially cultured in DMEM containing 10% FBS until confluence on 3.5-cm. plastic dishes (Becton Dickinson, NJ). Human mesothelial cells were infected with AdCMV.NK4 at various multiplicity of infection (MOI) ranging from 0 to 200 for 90 min and the infected cells were rinsed and incubated with a fresh medium. After 3 days, culture media were collected. The concentration of NK4 present in AdCMV.NK4-transfected mesothelial cells conditioned media was measured using an enzyme-linked immunosorbent assay (ELISA) kit for human HGF (Immunis HGF EIA; Institute of Immunology, Tokyo, Japan), according to the manufacturer's instructions. GBd1 cells were infected at various MOIs ranging from 0 to 300 for 90 min. The infected cells were rinsed and incubated with fresh medium. We determined the concentration of the NK4 protein in the supernatant for 7 days after AdCMV.NK4 infection.
Sensitivity and cytotoxicity of adenovirus vector to human mesothelial cells and GB-d1 cells
The transduction of b-galactosidase (b-gal) into human mesothelial cells passaged through four population doublings in culture were infected with AdCMV.LacZ. Human mesothelial cells were initially cultured in DMEM containing 10% FBS until confluent on 3.5-cm plastic dishes. These cells were infected with AdCMV.LacZ at various MOI (0,10, 50, 100, 200) for 90 minutes. After 1 day, the cells were fixed and stained with X-Gal using an X-Gal Staining Assay kit (Gene Therapy Systems, San Diego, CA). We evaluated the cell migration of GB-d1 cells by the use of a double chamber method. The GB-d1 cells were infected with AdCMV.NK4 (0, 12.5, 25, 50, 100, 200 MOI for 90 minutes) and the infected GB-d1cells were rinsed and incubated with fresh medium every 24 h. Three days, AdCMV.NK4-infected GB-d1 cells (10 4 ) suspended in DMEM containing 2% FBS were plated in the upper compartment of the chamber (Falcon cell culture inserts, Becton Dickinson, NJ) equipped with a filter membrane with 8-mm pores and human HGF (0-20 ng/ml) was added to the media of the lower well. Following incubation for 24 hours, the number of GB-d1cells that migrated through the filter membrane was counted after they had been stained with hematoxylin and eosin (H&E). Five microscopic fields ( Â 4) were randomly selected for cell counting.
Measurement of migration of GB-d1 cells under coculture with AdCMV.NK4-infected human mesothelial cells
Human mesothelial cells were cultured in DMEM containing 10% FBS until confluence on a lower well of the double chamber (MULTIWELLt 24WELL, Becton Dickinson, NJ). The human mesothelial cells were infected with AdCMV.NK4 (0, 12.5, 25, 50, 100, 200 MOI for 90 minutes) and the infected human mesothelial cells were rinsed and incubated with fresh medium. After 3 days, GB-d1 cells (10 4 ) suspended in DMEM containing 2% FBS were plated in the upper compartment of the chamber (Falcon cell culture inserts, Becton Dickinson, NJ) equipped with a filter membrane with 8-mm pores and human HGF (0-20 ng/ml) was added to the media with 2% FBS of the lower well. GB-d1 cells were cocultured with the AdCMV.NK4-infected human mesothelial cells. Following incubation for 24 hours, the number of GB-d1 cells that migrated through the filter membrane was counted as described above. Each type of cells was well distinguishable under H&E staining. No contamination of mesothelial cells to GB-d1 cell layer was observed.
Invasion assay
We measured the invasion of human gallbladder cancer cells using a matrigel (Matrix, Becton Dickinson, MA) coated chamber with an in vitro matrix membrane permeation model. Human mesothelial cells were initially cultured in DMEM containing 10% FBS until confluent on the lower well. The mesothelial cells were infected with AdCMV.NK4 (0, 12.5, 25, 50, 100, 200 MOI for 90 minutes) and the infected cells were rinsed and incubated with fresh medium every 24 h. After 3 days, GB-d1 cells suspended in DMEM containing 2% FBS (1 Â 10 4 cells) were plated in the upper compartment of the chamber, which was precoated with 60 mg of Matrigel and human HGF was added to a lower well. Following incubation for 24 hours, the number of cells that invaded through 8-mm pores of the membrane to the opposite side to the lower surface of filters was counted after they had been stained with H&E. Five microscopic fields ( Â 4) were randomly selected for cell counting.
Peritoneal metastasis model of mice
All of the animal experiments were performed under the guidelines established by Fukuoka University. Male athymic nude mice (BALB/c nu/nu) were obtained from Japan SLG. They were 4-6 weeks old and weighed an average of 18 g at the beginning of each experiment. The mice were anesthetized with diethyl ether. The skin over the abdomen was cleaned with povidone-iodine, and a 1 cm midline incision was made with surgical scissors. Next, four holes were made in the peritoneum and muscle using a 2.0 mm diameter ear puncher, resulting in four injuries in the peritoneum and muscle layer of each mouse.
Freshly harvested 5 Â 10 6 cells of GB-d1 that had been resuspended in DMEM were inoculated into peritoneal cavity after surgery. Thereafter, the midline incision was closed with interrupted sutures using 5-0 nylon and the skin at all injury sites was closed while the peritoneum there not closed. Next, either AdCMV.NK4 (2.5 Â 10 8 , 5 Â 10 8 , 1 Â 10 9 PFU/animal) or AdCMV.LacZ was administered to the peritoneal cavity of the mice. At 2 weeks after the administration, the mice were killed, the peritoneum was excised and the tumor size was measured. The tumor volume was estimated by the equation: (width) 2 Â (length) Â 1/2. Samples were fixed in 10% formalin, and embedded in paraffin, and 5-mm sections were prepared. These paraffin sections were stained with H&E.
Real-time quantitative reverse transcriptase/polymerase chain reaction
Mice were killed on days 0 (before injury; control), 1, 3, 5, 7, and 14 after injury. We removed about 100 mg of the injured peritoneum which included the normal peritoneum around the injury site. Total RNA was prepared from the samples using RNAzolt B (TEL-TEST, TX). In all 2 mg of total RNA was reverse-transcribed into first strand cDNA with TaqMan Reverse Transcription Reagents (Applied Biosystems, NJ). Quantitative polymerase chain reaction (PCR) was performed, using the Gene Amp 5700 Sequence Detection System (PerkinElmer Biosystems, Foster City, CA). The sequences for each primer were as follows: HGF, forward primer, 5 0 -CAC TGA CCC AAA CAT CCG AGT T-3 0 , reverse primer, 5 0 -TTG TCC CAC ATG GAA CAT GTA AG-3 0 , and control b-actin, forward primer, CTG CCT GAC GGC CAA GTC, reverse primer, CAA GAA GGA AGG CTG GAA AAG A. Experimental samples were matched to a standard curve generated by serially amplifying diluted products, using the same PCR protocol.
Statistical evaluation
The statistical values are presented as the mean7SD. All comparisons were made using the unpaired two-tailed
Results
Construction of
10 PFU/ml. Human mesothelial cells and GB-d1 cells were infected with AdCMV.NK4 at various MOIs ranging from 0 to 200 and the NK4 in the supernatant of these culture media was measured at 3 days after infection by ELISA. As shown in Table 1 , at an MOI of 50, NK4 secreted from AdCMV.NK4-infected mesothelial cells had a five times higher concentration than AdCMV.NK4-infected GB-d1 cells. When AdCMV.NK4 infected in more than 100 MOI in mesothelial or GB-d1 cells, a high concentration of NK4 was secreted from the infected cells. GB-d1 cells were infected with AdCMV.NK4 at 0, 3.6, 11, 33, 100, and 300 MOIs, and the culture media were collected on postinfection days 0, 1, 3, 5, and 7. The NK4 concentration in the medium of AdCMV.NK4-infected cells reached a plateau on day 3 after the infection and the secretion was maintained until the 7th day (Fig 1) .
Susceptibility and cytotoxicity of an adenovirus vector to human mesothelial cells and GB-d1 cells
To examine the efficiency of adenovirus vector transfection, we analyzed LacZ gene expression using X-gal staining in human mesothelial cells and GB-d1 cells which were infected with AdCMV.LacZ. in vitro. Notably, 100% of human mesothelial cells were stained with Xgal when an adenovirus vector infected with MOI of 10 or more (Figs 2a, c) . On the other hand, GB-d1 cells required an MOI of 200 to induce a 100% transfection (Figs 2b, c) . The cytotoxicity of an adenovirus vector was evaluated by counting the number of viable cells with a Coulter Counter after infection. Viable mesothelial cells gradually decreased in an MOI-dependent manner. At an MOI of 200, the number of viable mesothelial cells decreased to 48%. On the other hand, GB-d1 cells never showed any cellular toxicity at a 200 MOI.
Adenovirus vector can introduce 100% of the genes with a low MOI to human mesothelial cells but not to GB-d1 cells, they can do so with a high MOI.
Inhibition of HGF-induced migration of GB-d1 cells by AdCMV.NK4
We previously reported that the mitosis and invasion of GB-d1 cells were enhanced by HGF. 19, 20 We examined whether AdCMV.NK4 infection to cancer cells could prevent a cell migration. AdCMV.NK4-infected GB-d1 cells were cultured in a double chamber in the absence or presence of HGF. As shown in Figure 3 , HGF stimulated cell migration of GB-d1 in a dose-dependent manner. However, after AdCMV.NK4 infection, the number of migrating cells decreased in an MOI-dependent manner.
Inhibition of the migration and invasion of HGF-induced GB-d1 cells under coculture with AdCMV.NK4-infected human mesothelial cells GB-d1 cells were cocultured with AdCMV.NK4-infected human mesothelial cells in a double chamber in vitro and the suppression of GB-d1 cell motility and invasion was examined. In this experiment, to avoid any direct cytotoxicity of the remnant virions, the mesothelial cells were rinsed well after infection. Figure 1 The time course of NK4 protein secretion from AdCMV.NK4 infected GB-d1 cells. Cultured GB-d1 cells were infected at various MOIs ranging from 0 to 300 for 90 minutes. The infected cells were rinsed and incubated with fresh medium every 24 hours. Cultured media were collected every days and the concentration of the NK4 protein was determined for 7 days by ELISA. ND, not determined.
HGF/NK4 gene therapy T Tanaka et al Figure 4a shows that the migration of GB-d1 cells induced by HGF was significantly inhibited when cocultured with AdCMV.NK4-infected mesothelial cells in an MOI-dependent manner. Especially, with an MOI of higher than 100, the mesothelial cells almost completely inhibited the migration of GB-d1 cells (the migrating cancer cell number was decreased to 1/50).
We next investigated whether AdCMV.NK4 could affect the invasion of GB-d1 cells induced by HGF. As expected, the invasion was also significantly inhibited in an MOI-dependent manner. When AdCMV.NK4 infected to the mesothelial cells at 200 MOI, the invasion of GB-d1 cells was almost completely inhibited (Fig 4b) .
AdCMV.NK4 inhibits gallbladder cancer development in a peritoneal metastasis mouse model
We previously showed that GB-d1 cells injected into the peritoneal cavity of nude mice were tumorigenic only at the injured site of the peritoneum. 26 On the other hand, in this experiment we treated the peritoneal metastasis of GB-d1 cells by purified AdCMV.NK4 (n ¼ 4 in each group). The abdominal walls of nude mice were injured and the mice were challenged with a GB-d1 cell suspension of 5 Â 10 6 cells/mouse. The purified virus at various doses from 0 to 200 MOI was injected into the peritoneal cavity. Tumors developed only at the injured sites after 14 days after infection of control virus (Fig 5a,  left panel) , but the tumor size significantly decreased due to the infection with AdCMV.NK4 virus (Fig 5a, right  panel) . No tumor nodule was also detected in the surface of peritoneum that was not injured in mice infected with AdCMV.LacZ or AdCMV.NK4.
A histological examination of implanted tumors was performed after the intraperitoneal inoculation of GB-d1 cells after adenovirus vector treatment. The implanted tumor was a solid tumor containing glandular structures; it was localized to sites where the muscle layer was damaged in the (Fig 5b, left panel) . The administration of 10 9 PFU AdAMV.NK4 into the peritoneal cavity caused tumors only recognized as minute nodules at the injured sites (Fig 5b, right panel) . The tumor volume that was formed in the abdominal wall was measured. In comparison with the control virus group, when AdCMV NK4 was given beyond 100 MOI, a significant suppression of the tumor volume was observed. (MOI 100: n ¼ 4, Po.0001, MOI 200: n ¼ 4, Po.0001) (Fig 5c) .
Elevation of HGF mRNA at the peritoneal injury site
To investigate the local expression of HGF in response to injury, we analyzed mouse HGF mRNA at the injury sites of the peritoneum (day 0; control) up to 14 days after surgery. Total RNA was prepared from these tissue specimens and the mouse HGF mRNA levels were examined by real-time PCR (Fig 6) . At the peritoneal surgical injury sites, HGF mRNA expression increased as early as day 1 after peritoneal injury. The expression of HGF mRNA increased rapidly on day 3 after peritoneal injury (6.271.3 times of the normal peritoneum level; Po.05). The HGF mRNA level in the peritoneal injury sites reached a peak on day 5 (1271.2 times of the normal peritoneum level; Po.01), and then rapidly decreased on day 7, and thereafter decreased to the control level by day 14.
Discussion
Biliary cancers including gallbladder cancer are aggressive. When a palliative operation is performed on late stage gallbladder cancer, then metastasis, dissemination or recurrence at the operative wound of the liver, peritoneum or surround tissues has often been seen to occur. Local and systemic regression is often induced after surgical intervention.
We previously established a nude mouse model of gallbladder cancer metastasis to the injuered peritoneal sites. 26 In this model, these wounded sites are more preferable for gallbladder cancer cells to implant and survive, and metastatic nodules thus form selectively at these sites. In this paper, we demonstrated that HGF mRNA increases at the wounded sites for several days after injury and that the adenovirus vector expressing HGF antagonist (HGF/NK4) suppresses the tumor formation at the sites, thus suggesting that HGF from injury sites plays an important role in the peritoneal implantation and establishment of metastasis of gallbladder cancer.
HGF mRNA elevation examined by real-time PCR method was detectable at 3 days after wounding (Fig 6) . It reached a peak on the 5th day (about 12 times to the control level). Thereafter, mRNA decreased to the normal level within 7-14 days. We reported previously the wound healing of the injured peritoneum to be completed at 7 days after wounding (Aoki et al). An elevation of HGF mRNA and the wound healing process may be correlated with each other. HGF is reported to exist in various organs, liver, kidney and lung. [27] [28] [29] In vitro experiments revealed that, when organ injury occurs, HGF is activated and thus plays an important role in organ regeneration and tissue repair. [30] [31] [32] [33] The activated form of HGF was also detected clinically in the ascitic fluid of patients Figure 3 The suppression of GB-d1 migration by AdCMV.NK4 infection. GB-d1 cells were infected with AdCMV.NK4 at various MOIs ranging from 0 to 200. After 3 days, AdCMV.NK4-infected GB-d1 cells were cultured in a double chamber in the absence and presence of HGF for 24 hours. The migration potential of AdCMV.NK4-infected GB-d1 cells were evaluated. The error bar is expressed as the mean7SD.
HGF/NK4 gene therapy T Tanaka et al undergoing surgical abdominal operations depending on the extent of invasiveness in the body. 34 GB-d1 cells express a high-level c-met product (HGFR). In addition, the motility and invasion of GB-d1 cells are dramatically activated by HGF (10 ng/ml) as shown in Figures 3 and 4 . It is suggested that the implantation and metastasis of GB-d1 cells to the injured sites are associated with the elevation of HGF.
In our gallbladder cancer metastasis model, gene therapy with the adenovirus vector AdCMV.NK4 was found to suppress effectively the development of metastatic cancer nodules (Fig 5) . This result is probably not due to the direct cytotoxicity of the virus particles but to the successful production of NK4 protein by cancer cells and mesothelial cells. In vitro experiments, virus particles were purified by CsCl gradient centrifugation and its cytotoxicity to GB-d1 cells was minimal up to an MOI of 200 (Fig 2b) . A substantial level of NK4 protein was detected in the culture media of infected GB-d1 cells. After infection with the virus, both the motility and invasion, activated by 20 ng/ml HGF of the GB-d1 cells examined in the double chamber experiments were completely inhibited (Fig 4) . A successful suppression was similar to the results using purified NK4 protein as reported previously by Date et al. 19, 20 In general, cancer targeting gene therapy needs selectivity and effectiveness to the target cells, but it is difficult to achieve a 100% transduction of the gene into cancer cells selectively. In contrast, the target cells of our antagonist therapy do not require cancer cells. In our intraperitoneal injection experiments, peritoneal mesothelial cells should be also good candidate for gene transduction as well as cancer cells. Table 1 showed that the human mesothelial cells were susceptible to the vector virus and produced sufficient amount of a NK4 product to antagonize HGF. Although the cultured mesothelial cells were somewhat fragile after the virus infection, they produced a high level of NK4 at a lower MOI (50 PFU/ cell). Actually, the double chamber method indicated that the invasion of GB-d1 cells stimulated by 20 ng/ml of HGF was inhibited when cocultured with mesothelial cells infected with the virus. Mesothelial cells would thus be (100-300 mg/10 6 cells) was produced for more than 6 weeks. 35 By ex vivo experiment that the mesothelial cells infected with the virus were injected into the mouse peritoneum, they produced GH for 3 weeks. Nagy et al 36, 37 advocated the usefulness of the mesothelial cells for gene therapy. They claimed that mesothelial cells, by virtue of their anatomical location and the draining lymphatics that connect all cavities with the blood, are in direct communication with the systemic circulation. We assume that, in the clinical situation, mesothelial cells may be responsible for producing gene products because of numerical superiority of mesothelial cells and demise of cancer cells during the treatment.
The mechanism of tumor suppression by NK4 is reported to not only be the antagonization of HGF action but also an antiangiogenic activity. 38 Kuba et al showed that the antiangiogenic activity might correlate with other unknown products than an HGF receptor of human endothelial cells. In NK4 gene therapy of a pancreas cancer model as reported by Saimura et al, they repeated the administration of the virus for 4-5 weeks to suppress cancer development. They emphasized the importance of an antiangiogenic function of NK4 to suppress tumor formation. 39 In our experiments, however, angiogenesis may not be important, but the implantation and development of the tumor nodules may be remarked, because we evaluated tumor formation within 2 weeks after treatment.
HGF is believed to be an essential factor for organogenesis, embryogenesis and regeneration of various injured tissue and organs. Unfortunately, HGF may enhance the adenocarcinoma development simultaneously with tissue repair, because adenocarcinoma cells are derived from epithelial cells expressing a high level of HGFR. HGF may be one of the important factors that cause cancer metastasis to the wounded lesion after palliative operations. Antagonist gene therapy of HGF/ NK4 would be effective to control the cancer regression associated with tissue repair or recovery after surgical intervention.
In summary, we demonstrated that the transduction of the adenovirus-mediated NK4 gene to the peritoneal cavity could be achieved by intraperitoneal viral injections, and significantly suppressed peritoneal metastasis of the tumor that selectively developed at the abdominal injury sites. NK4 gene transfer may therefore be an effective modality for preventing peritoneal metastasis of gallbladder cancer. Figure 6 Elevation of mouse HGF mRNA expression in the injured peritoneum. The peritoneum of the mice was injured with a 2 mm ear puncher as described in the Materials and methods. Thereafter, the mice were killed on days 0, 1, 3, 5, 7 and 14. The total RNA of the injured peritoneal tissue was prepared at each time point and HGF mRNA levels were determined by real-time quantitative RT-PCR. Each value (times of control) represents the mean7SD of values obtained using three mice at each time point. *P ¼ .05, **P ¼ .001 versus the control.
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